Literature DB >> 8030193

Detection of pig farms with Ornithodoros erraticus by pig serology. Elimination of non-specific reactions by carbohydrate epitopes of salivary antigens.

A Oleaga-Pérez1, R Pérez-Sánchez, A Astigarraga, A Encinas-Grandes.   

Abstract

Ornithodoros erraticus is the European vector of African Swine Fever. It is therefore essential to know on which pig farms the tick is present in order to prevent contact with swine. Currently, studies are being made to ascertain this through the detection of anti-O. erraticus antibodies in the sera of swine, using three extracts from the salivary glands of the parasite (SGE): a complete extract (SGE-1), a soluble antigens extract (SGE-2), and a tissue antigens extract (SGE-3). The results of the present work show that SGE-2 gives the best differentiation between swine bitten by O. erraticus and unbitten swine in the enzyme-linked immunosorbent assay (ELISA). Using this extract, an optical density (OD) five-fold higher than the basal OD indicates that the pigs carry anti-O. erraticus antibodies. A serological study carried out in Salamanca with 8083 sera from 1756 pig farms revealed the presence of the parasite on 135 farms. However, during this study we noticed that some sera of unbitten animals gave false-positive reactions. Western blot analysis of SGE-2 of these false-positive sera demonstrated the same bands (except for two) as the real anti-O. erraticus sera. We observed, in ELISA and Western blot analysis, that such false-positive sera only recognised carbohydrate epitopes on SGE-2. This reactivity disappeared on deglycosylated SGE-2 (SGE-2-P). Therefore, SGE-2-P is the antigen that confers the greatest specificity to serology. In this study it was also observed that the low levels of anti-O. erraticus antibodies found in some cases may be because the swine were bitten some months previously on a different farm or that the current farm harboured only a few specimens of O. erraticus, so pig-tick contact is unlikely and hence the pigs either only develop a primary response or the time between contacts is very long and the levels of antibodies fall. Since pigs could be bitten on a different farm, the presence of low levels of anti-O. erraticus antibodies in pig sera do not necessarily indicate the presence of the tick on the farm where sampling was carried out.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8030193     DOI: 10.1016/0304-4017(94)90040-x

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  5 in total

1.  Ornithodoros porcinus ticks, bushpigs, and African swine fever in Madagascar.

Authors:  F Roger; J Ratovonjato; P Vola; G Uilenber
Journal:  Exp Appl Acarol       Date:  2001       Impact factor: 2.132

2.  First detection of African Swine Fever Virus in Ornithodoros porcinus in Madagascar and new insights into tick distribution and taxonomy.

Authors:  Julie Ravaomanana; Vincent Michaud; Ferran Jori; Abel Andriatsimahavandy; François Roger; Emmanuel Albina; Laurence Vial
Journal:  Parasit Vectors       Date:  2010-11-30       Impact factor: 3.876

3.  African swine fever virus transmission cycles in Central Europe: Evaluation of wild boar-soft tick contacts through detection of antibodies against Ornithodoros erraticus saliva antigen.

Authors:  Jana Pietschmann; Lina Mur; Sandra Blome; Martin Beer; Ricardo Pérez-Sánchez; Ana Oleaga; José Manuel Sánchez-Vizcaíno
Journal:  BMC Vet Res       Date:  2016-01-04       Impact factor: 2.741

4.  Humoral immune response of pigs, Sus scrofa domesticus, upon repeated exposure to blood-feeding by Ornithodoros turicata Duges (Ixodida: Argasidae).

Authors:  Hee J Kim; Aparna Krishnavajhala; Brittany A Armstrong; Adalberto A Pérez de León; Serhii Filatov; Pete D Teel; Job E Lopez
Journal:  Parasit Vectors       Date:  2020-02-12       Impact factor: 3.876

5.  Phylodynamics and evolutionary epidemiology of African swine fever p72-CVR genes in Eurasia and Africa.

Authors:  Moh A Alkhamis; Carmina Gallardo; Cristina Jurado; Alejandro Soler; Marisa Arias; José M Sánchez-Vizcaíno
Journal:  PLoS One       Date:  2018-02-28       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.